Yousif Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.19M Sell
15,051
-3,447
-19% -$677K 0.04% 464
2026
Q1
$3.63M Sell
18,498
-994
-5% -$193K 0.04% 408
2025
Q4
$3.68M Sell
19,492
-899
-4% -$164K 0.04% 419
2025
Q3
$3.89M Sell
20,391
-1,585
-7% -$281K 0.04% 412
2025
Q2
$3.95M Buy
21,976
+4,195
+24% +$729K 0.04% 403
2025
Q1
$3.01M Sell
17,781
-591
-3% -$97.1K 0.03% 504
2024
Q4
$2.77M Sell
18,372
-5,375
-23% -$836K 0.03% 571
2024
Q3
$3.69M Sell
23,747
-443
-2% -$66.2K 0.04% 439
2024
Q2
$3.31M Sell
24,190
-410
-2% -$56.1K 0.04% 489
2024
Q1
$3.27M Sell
24,600
-502
-2% -$65.1K 0.04% 535
2023
Q4
$3.46M Sell
25,102
-1,236
-5% -$162K 0.04% 494
2023
Q3
$3.21M Sell
26,338
-588
-2% -$78.3K 0.04% 492
2023
Q2
$3.78M Buy
26,926
+1,359
+5% +$187K 0.05% 426
2023
Q1
$3.62M Sell
25,567
-278
-1% -$39.8K 0.05% 431
2022
Q4
$4.04M Buy
25,845
+1,369
+6% +$197K 0.05% 388
2022
Q3
$3M Buy
24,476
+4,390
+22% +$578K 0.04% 474
2022
Q2
$2.67M Sell
20,086
-2,115
-10% -$288K 0.04% 609
2022
Q1
$3.04M Sell
22,201
-5,102
-19% -$711K 0.03% 629
2021
Q4
$4.72M Buy
+27,303
New +$4.15M 0.05% 417

Other funds holding DGX

Yousif Capital Management's DGX Position: Q2 2026 in Review

Yousif Capital Management reduced its Quest Diagnostics (DGX) stake by 19% in Q2 2026, selling an estimated $677K and leaving 15,051 shares worth $3.19M. The position accounts for 0.04% of the portfolio, ranked #464.

Yousif Capital Management first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.72M in Q4 2021. 239 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Yousif Capital Management held 15,051 shares of Quest Diagnostics worth $3.19M as of Q2 2026.
  • Yousif Capital Management sold 3,447 Quest Diagnostics shares in Q2 2026, an estimated $677K.
  • Quest Diagnostics made up 0.04% of Yousif Capital Management's portfolio in Q2 2026, its #464 holding.
  • Yousif Capital Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Quest Diagnostics position peaked at $4.72M in Q4 2021.
  • 239 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.